These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2922356)
1. Simulation of vancomycin peak and trough concentrations using five dosing methods in 37 patients. Zokufa HZ; Rodvold KA; Blum RA; Riff LJ; Fischer JH; Crossley KB; Rotschafer JC Pharmacotherapy; 1989; 9(1):10-6. PubMed ID: 2922356 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections. Adane ED; Herald M; Koura F Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of three methods for determining initial vancomycin doses. Ackerman BH DICP; 1989 Feb; 23(2):123-8. PubMed ID: 2728500 [TBL] [Abstract][Full Text] [Related]
4. Accuracy of Bayesian, Sawchuk-Zaske, and nomogram dosing methods for vancomycin. Garrelts JC; Godley PJ; Horton MW; Karboski JA Clin Pharm; 1987 Oct; 6(10):795-9. PubMed ID: 3505841 [TBL] [Abstract][Full Text] [Related]
5. Individualized adjustment of vancomycin dosage: comparison with two dosage nomograms. Rybak MJ; Boike SC Drug Intell Clin Pharm; 1986 Jan; 20(1):64-8. PubMed ID: 3943460 [TBL] [Abstract][Full Text] [Related]
6. Vancomycin population pharmacokinetics in neonates. de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244 [TBL] [Abstract][Full Text] [Related]
7. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients. Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639 [TBL] [Abstract][Full Text] [Related]
8. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients. Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a new vancomycin dosing method. Musa DM; Pauly DJ Pharmacotherapy; 1987; 7(3):69-72. PubMed ID: 3628064 [TBL] [Abstract][Full Text] [Related]
10. Modified vancomycin dosing protocol for treatment of diabetic foot infections. Niu SC; Deng ST; Lee MH; Ho C; Chang HY; Liu FH Am J Health Syst Pharm; 2008 Sep; 65(18):1740-3. PubMed ID: 18769001 [TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis. Stockmann C; Sherwin CM; Zobell JT; Lubsch L; Young DC; Olson J; Noyes BE; Ampofo K; Spigarelli MG Pharmacotherapy; 2013 Dec; 33(12):1288-96. PubMed ID: 23824677 [TBL] [Abstract][Full Text] [Related]
12. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation. Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127 [TBL] [Abstract][Full Text] [Related]
14. Vancomycin pharmacokinetics in infants: relationship to postconceptional age and serum creatinine. Kildoo CW; Lin LM; Gabriel MH; Folli HL; Modanlou HD Dev Pharmacol Ther; 1989; 14(2):77-83. PubMed ID: 2630235 [TBL] [Abstract][Full Text] [Related]
15. A Strategy for Dosing Vancomycin to Therapeutic Targets Using Only Trough Concentrations. Prybylski JP Clin Pharmacokinet; 2017 Mar; 56(3):263-272. PubMed ID: 27389404 [TBL] [Abstract][Full Text] [Related]
16. Application of a Bayesian method to monitor and adjust vancomycin dosage regimens. Hurst AK; Yoshinaga MA; Mitani GH; Foo KA; Jelliffe RW; Harrison EC Antimicrob Agents Chemother; 1990 Jun; 34(6):1165-71. PubMed ID: 2393277 [TBL] [Abstract][Full Text] [Related]
17. Individualized vancomycin dosing in obese patients: a two-sample measurement approach improves target attainment. Hong J; Krop LC; Johns T; Pai MP Pharmacotherapy; 2015 May; 35(5):455-63. PubMed ID: 26011138 [TBL] [Abstract][Full Text] [Related]